28 results on '"Azaiez S"'
Search Results
2. Synthesis and characterization of promising biochars for hexavalent chromium removal: application of response surface methodology approach
- Author
-
Khalifa, E. Ben, Azaiez, S., Magnacca, G., Cesano, F., Benzi, P., and Hamrouni, B.
- Published
- 2023
- Full Text
- View/download PDF
3. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency
- Author
-
Tabbene, O., Azaiez, S., Di Grazia, A., Karkouch, I., Ben Slimene, I., Elkahoui, S., Alfeddy, M. N., Casciaro, B., Luca, V., Limam, F., and Mangoni, M. L.
- Published
- 2016
- Full Text
- View/download PDF
4. Multiagent oriented modelling and simulation for manufacturing systems control
- Author
-
Azaiez, S., Habchi, Georges, Huget, Marc-Philippe, Pralus, Magali, Tounsi, Jihène, Symme, Univ. Savoie Mont Blanc, Laboratoire d'Informatique, Systèmes, Traitement de l'Information et de la Connaissance (LISTIC), Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry]), and Laboratoire SYstèmes et Matériaux pour la MEcatronique (SYMME)
- Subjects
[INFO.INFO-MO] Computer Science [cs]/Modeling and Simulation ,[INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2007
5. P-048: Antihypertensive treatment in peritoneal dialysis
- Author
-
Azaiez, S., Ounissi, M., Mannai, K., and Ben Abdallah, T.
- Published
- 2015
- Full Text
- View/download PDF
6. Atteintes glomérulaires au cours du myélome multiple : facteurs prédictifs et étude de survie.
- Author
-
Azaiez, S., Barbouch, S., Aoudia, R., Goucha, R., Kaaroud, H., Hamida, F. Ben, Harzallah, A., and Abdallah, T. Ben
- Abstract
Introduction Le myélome multiple se complique dans plus de la moitié des cas d’une atteinte tubulaire rénale et d’une insuffisance rénale, facteur pronostique qui figure dans la classification de Durie–Salmon. Par contre, les atteintes glomérulaires associées au myélome multiple sont rares et rapportées dans quelques séries de cas. Leur évolution et leur pronostic sont peu étudiés. Patients/matériels et méthodes Il s’agit d’une étude rétrospective analytique incluant des patients chez qui le diagnostic de myélome multiple a été retenu, sur une période de 33 années allant de janvier 1983 à décembre 2015. Nous avons relevé les principales caractéristiques des malades. Les facteurs prédictifs de néphropathies glomérulaires et leur pronostic ont été recherchés. Résultats Nous avons inclus 22 patients ayant une néphropathie glomérulaire compliquant un myélome multiple. L’âge médian était de 55,5 ± 10,9 ans (extrêmes : 41–75). Douze patients avaient un âge inférieur à 60 ans au diagnostic. Le sex-ratio était de 1,2. Une protéinurie a été retrouvée aux bandelettes urinaires dans 19 cas et une hématurie dans 14 cas. La clairance de la créatinine médiane était de 25,6 ± 28,3 mL/min (extrêmes : 3,8–114,9). Seize patients avaient une insuffisance rénale secondaire au myélome multiple. Un myélome multiple à IgG Kappa était retrouvé dans deux cas et un myélome multiple à chaînes légères dans sept cas. Trois malades étaient classés au stade I, cinq au stade II et 14 au stade III de Durie–Salmon. Ces malades avaient une amylose AL dans 16 cas, une maladie de Randall dans cinq cas et une glomérulonéphrite extramembraneuse dans un cas. Les cylindres myélomateux étaient associés dans quatre cas. La médiane de survie rénale à 12 mois était de 54 %, corrélée au tabagisme (p = 0,01), à l’insuffisance rénale initiale (p = 0,02), à l’uricémie > 600 μmol/L (p = 0,003) et à la progression sous traitement (p = 0,02). La médiane de survie globale était de 17 mois, influencée par une calcémie > 2,8 mmol/L (p = 0,002), une phosphorémie > 2 mmol/L (p = 0,001) et le stade III (p = 0,03). Après comparaison avec 27 malades sans atteinte rénale, les facteurs prédictifs d’une néphropathie glomérulaire étaient la protéinurie (p = 0,04), des phosphatases alcalines élevées (p = 0,02) et l’absence du type IgG Kappa (p = 0,02). Conclusion Les néphropathies glomérulaires associées au myélome multiple sont peu fréquentes, parfois sous-diagnostiquées et présentent des caractéristiques clinicobiologiques particulières avec un pronostic et une survie rénale et globale nettement défavorables. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3)
- Author
-
Von Seth, M., Hillered, L., Otterbeck, A., Hanslin, K., Larsson, A., Sjölin, J., Lipcsey, M., Cove, ME, Chew, N. S., Vu, L. H., Lim, R. Z., Puthucheary, Z., Wilske, F., Skorup, P., Tano, E., Derese, I., Thiessen, S., Derde, S., Dufour, T., Pauwels, L., Bekhuis, Y., Van den Berghe, G., Vanhorebeek, I., Khan, M., Dwivedi, D., Zhou, J., Prat, A., Seidah, N. G., Liaw, P. C., Fox-Robichaud, A. E., Correa, T., Pereira, J, Takala, J, Jakob, S, Maudsdotter, L., Castegren, M., Sjölin, J, Xue, M., Xu, J. Y., Liu, L., Huang, Y. Z., Guo, F. M., Yang, Y., Qiu, H. B., Kuzovlev, A., Moroz, V., Goloubev, A., Myazin, A., Chumachenko, A., Pisarev, V., Takeyama, N., Tsuda, M., Kanou, H., Aoki, R., Kajita, Y., Hashiba, M., Terashima, T., Tomino, A., Davies, R., O’Dea, K. P., Soni, S., Ward, J. K., O’Callaghan, D. J., Takata, M., Gordon, A. C., Wilson, J., Zhao, Y., Singer, M., Spencer, J., Shankar-Hari, M., Genga, K. Roveran, Lo, C., Cirstea, M. S., Walley, K. R., Russell, J. A., Linder, A., Boyd, J. H., Sedlag, A., Riedel, C., Georgieff, M., Barth, E., Bracht, H., Essig, A., Henne-Bruns, D., Gebhard, F., Orend, K., Halatsch, M., Weiss, M., Chase, M., Freinkman, E., Uber, A., Liu, X., Cocchi, M. N., Donnino, M. W., Peetermans, M., Liesenborghs, L., Claes, J., Vanassche, T., Hoylaerts, M., Jacquemin, M., Vanhoorelbeke, K., De Meyer, S., Verhamme, P., Vögeli, A., Ottiger, M., Meier, M., Steuer, C., Bernasconi, L., Huber, A., Christ-Crain, M., Henzen, C., Hoess, C., Thomann, R., Zimmerli, W., Müller, B., Schütz, P., Hoppensteadt, D., Walborn, A., Rondina, M., Tsuruta, K., Fareed, J., Tachyla, S., Ikeda, T., Ono, S., Ueno, T., Suda, S., Nagura, T., Damiani, E., Domizi, R., Scorcella, C., Tondi, S., Pierantozzi, S., Ciucani, S., Mininno, N., Adrario, E., Pelaia, P., Donati, A., Andersen, M. Schou, Lu, S., Lopez, G, Lassen, AT, Ghiran, I., Shapiro, N. I., Trahtemberg, U., Sviri, S., Beil, M., Agur, Z., Van Heerden, P., Jahaj, E., Vassiliou, A., Mastora, Z., Orfanos, S. E., Kotanidou, A., Wirz, Y., Sager, R., Amin, D., Amin, A., Haubitz, S., Hausfater, P., Kutz, A., Mueller, B., Schuetz, P., Sager, R. S., Wirz, Y. W., Amin, D. A., Amin, A. A., Hausfater, P. H., Huber, A. H., Mueller, B, Schuetz, P, Gottin, L., Dell’amore, C., Stringari, G., Cogo, G., Ceolagraziadei, M., Sommavilla, M., Soldani, F., Polati, E., Baumgartner, T., Zurauskaité, G., Gupta, S., Devendra, A., Mandaci, D., Eren, G., Ozturk, F., Emir, N., Hergunsel, O., Azaiez, S., Khedher, S., Maaoui, A., Salem, M., Chernevskaya, E., Beloborodova, N., Bedova, A., Sarshor, Y. U., Pautova, A., Gusarov, V., Öveges, N., László, I., Forgács, M., Kiss, T., Hankovszky, P., Palágyi, P., Bebes, A., Gubán, B., Földesi, I., Araczki, Á., Telkes, M., Ondrik, Z., Helyes, Z., Kemény, Á., Molnár, Z., Spanuth, E., Ebelt, H., Ivandic, B., Thomae, R., Werdan, K., El-Shafie, M., Taema, K., El-Hallag, M., Kandeel, A., Tayeh, O., Eldesouky, M., Omara, A., Winkler, M. S., Holzmann, M., Nierhaus, A., Mudersbach, E., Schwedhelm, E., Daum, G., Kluge, S., Zoellner, C., Greiwe, G., Sawari, H., Kubitz, J., Jung, R., Reichenspurner, H., Groznik, M., Ihan, A., Andersen, L. W., Holmberg, M. J., Wulff, A., Balci, C., Haliloglu, M., Bilgili, B., Bilgin, H., Kasapoglu, U., Sayan, I., Süzer, M., Mulazımoglu, L., Cinel, I., Patel, V., Shah, S., Parulekar, P., Minton, C., Patel, J., Ejimofo, C., Choi, H., Costa, R., Caruso, P., Nassar, P., Fu, J., Jin, J., Xu, Y., Kong, J., Wu, D., Yaguchi, A., Klonis, A., Ganguly, S., Kollef, M., Burnham, C., Fuller, B., Mavrommati, A., Chatzilia, D., Salla, E., Papadaki, E., Kamariotis, S., Christodoulatos, S., Stylianakis, A., Alamanos, G., Simoes, M., Trigo, E., Silva, N., Martins, P., Pimentel, J., Baily, D., Curran, L. A., Ahmadnia, E., Patel, B. V., Adukauskiene, D., Cyziute, J, Adukauskaite, A., Pentiokiniene, D., Righetti, F., Colombaroli, E., Castellano, G., Man, M., Shum, H. P., Chan, Y. H., Chan, K. C., Yan, W. W., Lee, R. A., Lau, S. K., Dilokpattanamongkol, P., Thirapakpoomanunt, P., Anakkamaetee, R., Montakantikul, P., Tangsujaritvijit, V., Sinha, S., Pati, J., Sahu, S., Valanciene, D., Dambrauskiene, A., Hernandez, K., Lopez, T., Saca, D., Bello, M., Mahmood, W., Hamed, K., Al Badi, N., AlThawadi, S., Al Hosaini, S., Salahuddin, N., Cilloniz, C. C., Ceccato, A. C., Bassi, G. L. Li, Ferrer, M. F., Gabarrus, A. G., Ranzani, O. R., Jose, A. S. San, Vidal, C. G. Garcia, de la Bella Casa, J. P. Puig, Blasi, F. B., Torres, AT, Ciginskiene, A., Simoliuniene, R., Giuliano, G., Triunfio, D., Sozio, E., Taddei, E., Brogi, E., Sbrana, F., Ripoli, A., Bertolino, G., Tascini, C., Forfori, F., Fleischmann, C., Goldfarb, D., Schlattmann, P., Schlapbach, L., Kissoon, N., Baykara, N., Akalin, H., Arslantas, M. Kemal, Gavrilovic, S. G., Vukoja, M. V., Hache, M. H., Kashyap, R. K., Dong, Y. D., Gajic, O. G., Ranzani, O., Harrison, D., Rabello, L., Rowan, K., Salluh, J., Soares, M., Markota, A. M., Fluher, J. F., Kogler, D. K., Borovšak, Z. B., Sinkovic, A. S., Siddiqui, Z, Aggarwal, P., Iqbal, O., Lewis, M., Wasmund, R., Abro, S., Raghuvir, S., Barie, P. S., Fineberg, D., Radford, A., Casazza, A., Vilardo, A., Bellazzi, E., Boschi, R., Ciprandi, D., Gigliuto, C., Preda, R., Vanzino, R., Vetere, M., Carnevale, L., Kyriazopoulou, E., Pistiki, A., Routsi, C., Tsangaris, I., Giamarellos-Bourboulis, E., Pnevmatikos, I., Vlachogiannis, G., Antoniadou, E., Mandragos, K., Armaganidis, A., Allan, P., Oehmen, R., Luo, J., Ellis, C., Latham, P., Newman, J., Pritchett, C., Pandya, D., Cripps, A., Harris, S., Jadav, M., Langford, R., Ko, B., Park, H., Beumer, C. M., Koch, R., Beuningen, D. V., Oudelashof, A. M., Vd Veerdonk, F. L., Kolwijck, E., VanderHoeven, J. G., Bergmans, D. C., Hoedemaekers, C., Brandt, J. B., Golej, J., Burda, G., Mostafa, G., Schneider, A., Vargha, R., Hermon, M., Levin, P., Broyer, C, Assous, M., Wiener-Well, Y., Dahan, M., Benenson, S., Ben-Chetrit, E, Faux, A., Sherazi, R., Sethi, A., Saha, S., Kiselevskiy, M., Gromova, E., Loginov, S., Tchikileva, I., Dolzhikova, Y., Krotenko, N., Vlasenko, R., Anisimova, N., Spadaro, S., Fogagnolo, A., Remelli, F., Alvisi, V., Romanello, A., Marangoni, E., Volta, C., Degrassi, A., Mearelli, F., Casarsa, C., Fiotti, N., Biolo, G., Cariqueo, M., Luengo, C., Galvez, R., Romero, C., Cornejo, R., Llanos, O., Estuardo, N., Alarcon, P., Magazi, B., Khan, S., Pasipanodya, J., Eriksson, M., Strandberg, G., Lipsey, M., Rajput, Z., Hiscock, F., Karadag, T., Uwagwu, J., Jain, S., Molokhia, A., Barrasa, H., Soraluce, A., Uson, E., Rodriguez, A., Isla, A., Martin, A., Fernández, B., Fonseca, F., Sánchez-Izquierdo, J. A., Maynar, F. J., Kaffarnik, M., Alraish, R., Frey, O., Roehr, A., Stockmann, M., Wicha, S., Shortridge, D., Castanheira, M., Sader, H. S., Streit, J. M., Flamm, R. K., Falsetta, K., Lam, T., Reidt, S., Jancik, J., Kinoshita, T., Yoshimura, J., Yamakawa, K., Fujimi, S., Torres, A., Zakynthinos, S., Mandragos, C., Ramirez, P., De la Torre-Prados, M., Dale, G., Wach, A., Beni, L., Hooftman, L., Zwingelstein, C., François, B., Colin, G., Dequin, P. F., Laterre, P. F., Perez, A., Welte, R., Lorenz, I., Eller, P., Joannidis, M., Bellmann, R., Lim, S., Chana, S., Patel, S., Higuera, J., Cabestrero, D., Rey, L., Narváez, G., Blandino, A., Aroca, M., Saéz, S., De Pablo, R, Albert, C. Nadège, Langouche, L., Goossens, C., Peersman, N., Vermeersch, P., Vander Perre, S., Holst, J., Wouters, P., Uber, A. U., Holmberg, M., Konanki, V., McNaughton, M., Zhang, J., Demirkiran, O., Byelyalov, A., Guerrero, J., Cariqueo, M, Rossini, N., Falanga, U., Monaldi, V., Cole, O., Scawn, N., Balciunas, M., Blascovics, I., Vuylsteke, A., Salaunkey, K., Omar, A., Salama, A., Allam, M., Alkhulaifi, A., Verstraete, S., Van Puffelen, E., Ingels, C., Verbruggen, S., Joosten, K., Hanot, J., Guerra, G., Vlasselaers, D., Lin, J., Haines, R., Zolfaghari, P., Hewson, R., Offiah, C., Prowle, J., Buter, H., Veenstra, J. A., Koopmans, M., Boerma, E. C., Taha, A., Shafie, A., Hallaj, S., Gharaibeh, D., Hon, H., Bizrane, M., El Khattate, A. A., Madani, N., Abouqal, R., Belayachi, J., Kongpolprom, N., Sanguanwong, N., Sanaie, S., Mahmoodpoor, A., Hamishehkar, H., Biderman, P., Avitzur, Y., Solomon, S., Iakobishvili, Z., Carmi, U., Gorfil, D, Singer, P., Paisley, C., Patrick-Heselton, J., Mogk, M., Humphreys, J., Welters, I., Casarotta, E., Bolognini, S., Moskowitz, A., Patel, P., Grossestreuer, A., Malinverni, S., Goedeme, D., Mols, P., Langlois, P. L., Szwec, C., D’Aragon, F., Heyland, D. K., Manzanares, W., Langlois, P., Aramendi, I., Heyland, D., Stankovic, N., Nadler, J., Sanchez, L., Wolfe, R., Donnino, M., Cocchi, M., Atalan, H. K., Gucyetmez, B., Kavlak, M. E., Aslan, S., Kargi, A., Yazici, S., Donmez, R., Polat, K. Y., Piechota, M, Piechota, A., Misztal, M., Bernas, S., Pietraszek-Grzywaczewska, I., Saleh, M., Hamdy, A., Elhallag, M., Atar, F., Kundakci, A., Gedik, E., Sahinturk, H., Zeyneloglu, P., Pirat, A., Popescu, M., Tomescu, D., Van Gassel, R., Baggerman, M., Schaap, F., Bol, M., Nicolaes, G., Beurskens, D., Damink, S. Olde, Van de Poll, M., Horibe, M., Sasaki, M., Sanui, M., Iwasaki, E., Sawano, H., Goto, T., Ikeura, T., Hamada, T., Oda, T., Mayumi, T., Kanai, T., Kjøsen, G., Horneland, R., Rydenfelt, K., Aandahl, E., Tønnessen, T., Haugaa, H., Lockett, P., Evans, L., Somerset, L., Ker-Reid, F., Laver, S., Courtney, E., Dalton, S., Georgiou, A., Robinson, K., Haas, B., Bartlett, K., Bigwood, M., Hanley, R., Morgan, P., Marouli, D., Chatzimichali, A., Kolyvaki, S., Panteli, A., Diamantaki, E., Pediaditis, E., Sirogianni, P., Ginos, P., Kondili, E., Georgopoulos, D., Askitopoulou, H., Zampieri, F. G., Liborio, A. B., Besen, B. A., Cavalcanti, A. B., Dominedò, C., Dell’Anna, A. M., Monayer, A., Grieco, D. L., Barelli, R., Cutuli, S. L., Maddalena, A. Ionescu, Picconi, E., Sonnino, C., Sandroni, C., Antonelli, M., Tuzuner, F., Cakar, N., Jacob, M., Sahu, S, Singh, Y. P., Mehta, Y., Yang, K. Y., Kuo, S., Rai, V., Cheng, T., Ertmer, C., Czempik, P, Hutchings, S., Watts, S., Wilson, C., Burton, C., Kirkman, E., Drennan, D., O’Prey, A., MacKay, A., Forrest, R., Oglinda, A., Ciobanu, G., Casian, M., Oglinda, C., Lun, C. T., Yuen, H. J., Ng, G., Leung, A., So, S. O., Chan, H. S., Lai, K. Y., Sanguanwit, P., Charoensuk, W., Phakdeekitcharoen, B., Batres-Baires, G., Kammerzell, I., Lahmer, T., Mayr, U., Schmid, R., Huber, W., Bomberg, H., Klingele, M., Groesdonk, H., Piechota, M., Mirkiewicz, K., Pérez, A. González, Silva, J., Ramos, A., Acharta, F., Perezlindo, M., Lovesio, L., Antonelli, P. Gauna, Dogliotti, A., Lovesio, C., Baron, J., Schiefer, J., Baron, D. M., Faybik, P., Chan, T. M., Ginos, P, Vicka, V., Gineityte, D., Ringaitiene, D., Sipylaite, J., Pekarskiene, J., Beurskens, D. M., Van Smaalen, T. C., Hoogland, P., Winkens, B., Christiaans, M. H., Reutelingsperger, C. P., Van Heurn, E., Nicolaes, G. A., Schmitt, F. S., Salgado, E. S., Friebe, J. F., Fleming, T. F., Zemva, J. Z., Schmoch, T. S., Uhle, F. U., Kihm, L. K., Morath, C. M., Nusshag, C. N., Zeier, M. Z., Bruckner, T. B., Mehrabi, A. M., Nawroth, P. N., Weigand, M. W., Hofer, S. H., Brenner, T. B., Fotopoulou, G., Poularas, I., Kokkoris, S., Brountzos, E., Elghonemi, M., Nilsson, K. F., Sandin, J., Gustafsson, L., Frithiof, R., Skorniakov, I., Varaksin, A., Vikulova, D., Shaikh, O., Whiteley, C., Ostermann, M., Di Lascio, G., Anicetti, L., Bonizzoli, M., Fulceri, G., Migliaccio, M. L., Sentina, P., Cozzolino, M., Peris, A., Khadzhynov, D., Halleck, F., Staeck, O., Lehner, L., Budde, K., Slowinski, T., Kindgen-Milles, D., Huysmans, N., Laenen, M. Vander, Helmschrodt, A., Boer, W., Debain, A., Jonckheer, J., Moeyersons, W., Van zwam, K., Puis, L., Staessens, K., Honoré, P. M., Spapen, H. D., De Waele, E., de Garibay, A. Perez Ruiz, Ende-Schneider, B., Schreiber, C., Kreymann, B., Bini, A., Votino, E., Steinberg, I., Vetrugno, L., Trunfio, D., Sidoti, A., Conroy, M., Marsh, B., and O’Flynn, J
- Subjects
Critical Care and Intensive Care Medicine ,Meeting Abstracts - Full Text
- View/download PDF
8. Effet de la menthe sur la lithiase oxalo-calcique.
- Author
-
Azaiez, S., Kharroubi, H., Ghabi, H., Kaaroud, H., Talbi, E., Baccouche, H., Bouzid, K., Ben Hamida, F., Ksouri, R., and Ben Abdallah, T.
- Abstract
Introduction La phytothérapie dans un but curatif ou préventif de la lithiase urinaire est largement utilisée par nos patients sans pour autant connaître le rôle aggravant ou bénéfique des plantes. Le but de ce travail est d’étudier l’effet de la menthe en infusion sur les promoteurs et les inhibiteurs de la lithogenèse au cours de la lithiase oxalo-calcique. Patients/matériels et méthodes Nous avons inclus dans cette étude prospective huit patients suivis pour une lithiase oxalo-calcique sous régime pauvre en oxalate comportant 6 à 8 g/j de sel, 1 g/j de calcium et 1 g/kg/j d’apport protidique. Nous avons analysé les composés phénoliques de la mentha piperita par chromatographie en phase liquide à haute performance. Les malades ont eu un dosage dans le sang (urée, créatinine, ionogramme, réserves alcalines, calcémie, phosphatémie, uricémie) et dans les urines (urée, créatinine, ionogramme, calciurie, phosphaturie, uricurie, oxalurie, citraturie, pH, densité urinaires) avant et après la prise d’infusion de menthe selon le protocole suivant : 5 g dans 250 mL d’eau (dilution 2 %), trois fois/j, pendant cinq jours. L’analyse statistique s’est basée sur l’étude des médianes pour les paramètres quantitatifs et l’utilisation du test de Wilcoxon pour la comparaison des médianes de ces variables avant et après la prise de la menthe. Résultats Il s’agit de cinq hommes et trois femmes, d’un âge médian de 56,5 ans (extrêmes : 41–58). Les composés phénoliques retrouvés dans la mentha piperita étaient l’acide férulique (0,73 mg/g de matière sèche) et l’acide rosmarinique (5,52 mg/g de matière sèche). Nous avons objectivé une diminution de l’oxalurie dans trois cas, de la calciurie dans trois cas et de l’uricurie dans trois cas et une augmentation de la citraturie dans six cas. L’analyse statistique des paramètres étudiés avant et après la prise de la menthe n’a pas montré de différence significative. Conclusion La phytothérapie à base de mentha piperita a démontré son efficacité sur l’inhibition de la formation des lithiases oxalo-calciques chez les rats. Cependant, cet effet reste mal étudié chez les hommes. Notre étude, incluant un effectif réduit, n’a pas retrouvé de différence sur les promoteurs et les inhibiteurs de la lithogenèse après utilisation de la menthe. Des études à plus grande échelle chez les hommes s’avèrent nécessaires. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Maladie de Randall : expérience d'un service de néphrologie.
- Author
-
Braiek, N., Barbouch, S., Fattoum, S., Hajji, M., Azaiez, S., Ben Nessira, S., Mayara, M., Ben Hmida, F., Ben Abdelghani, K., and Ben Abdallah, T.
- Abstract
La maladie de dépôts d'immunoglobuline monoclonale (MDIM) de type Randall est une entité maintenant bien individualisée au sein des gammapathies monoclonales de signification rénale (GMSR). Elle se définit par des dépôts linéaires de chaîne légère monoclonale (LCDD), ou de chaîne lourde (HCDD) ou des 2 (LHCDD) le long des membranes basales. Les objectifs de cette étude sont de décrire les caractéristiques cliniques, biologiques et évolutives de cette pathologie. Nous avons mené une étude rétrospective descriptive colligeant tous les cas de maladie de Randall diagnostiquée dans notre service de médecine interne A hôpital Charles-Nicolle durant une période de 45 ans, du 1er janvier 1974 au 31 juin 2019. Une maladie de Randall a été diagnostiquée dans 6 cas avec un âge moyen de 55 ans (extrême : 41–69 ans), il s'agissait de 5 hommes et une femme. Les circonstances de découverte étaient une hématurie microscopique dans deux cas, une hypertension artérielle (HTA) dans deux cas et une insuffisance rénale (IR) dans deux cas. Tous les malades avaient une insuffisance rénale sévère et qui ont nécessité le recours à l'épuration extrarénale (EER) dès le diagnostic. La ponction-biopsie rénale (PBR) était indiquée devant une néphropathie glomérulaire avec hématurie dans quatre cas et une IR sévère avec des reins de taille normale dans deux cas. La PBR révélait une glomérulosclérose nodulaire diffuse dans tous les cas qui était associée dans deux cas à un rein myélomateux. La coloration rouge Congo était négative dans tous les cas. Un patient a bénéficié d'une ponction-biopsie hépatique qui a montré un aspect en faveur de maladie de Randall avec des dépôts localisés au niveau des espaces de Disse et des membranes basales des canaux biliaires. Cinq patients ont bénéficié d'un protocole thérapeutique par voie orale à base de prédnisone 1 à 2 mg/kg/j associé au melphalan 0,25 mg/kg/j de j1 à j4 du mois, de façon mensuelle pendant un an. Un seul patient a été traité par bortézomib 1,3 mg/m2/j à j1, j4, j8 et j11 du mois en quatre cycles mensuels associé au dexaméthasone 40 mg/j de j1 à j4 du mois de chaque cycle. L'évolution était marquée par l'amélioration de la fonction rénale chez un patient et une dégradation avec EER chez cinq patients. La moyenne de survie rénale était 29,2 mois et la moyenne de survie globale était de 41,8 mois. Deux patients sont décédés aux cours de l'évolution dont les causes étaient une cachexie profonde chez un patient et une pneumopathie hypoximiante chez l'autre patient. La maladie des dépôts d'immunoglobulines monoclonales (MIDD) de type Randall est une complication rare des proliférations plasmocytaires monoclonales, L'atteinte rénale est quasi constante. Le traitement du syndrome de Randall reste mal codifié en raison de la rareté de cette entité. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Myélome multiple avec recours à l'hémodialyse au moment de diagnostic : profil clinicobiologique et évolutive.
- Author
-
Braiek, N., Barbouch, S., Hajji, M., Fattoum, S., Ben Nessira, S., Azaiez, S., Mayara, M., Ben Hmida, F., Gorsane, I., and Ben Abdallah, T.
- Abstract
Le myélome multiple (MM) est une hémopathie maligne caractérisée par la fréquence de l'atteinte rénale qui peut atteindre jusqu'à 50 % des patients. La sévérité de l'atteinte rénale et le recours à l'hémodialyse constituent des facteurs de risque péjoratifs de morbi-mortalité au cours du myélome multiple. Notre but était de préciser les caractéristiques des patients atteints d'un myélome hémodialysés au diagnostic ainsi que leurs particularités évolutives et pronostiques. Il s'agit d'une étude rétrospective descriptive s'étendant sur une période de 45 ans, du 1er janvier 1974 au 31 juin 2019 incluant tous les patients atteints de myélome pris en charge dans notre service de médecine interne A hôpital Charles-Nicolle et qui ont nécessité l'hémodialyse au moment de diagnostic. Nous avons colligé 144 cas dont 82 hommes et 62 femmes. L'âge moyen était de 63,36 ans. Tous les patients sont classés ISS III dont 81,94 % avaient une hémoglobine < 10 g/dL et 46,52 % avaient une hypercalcémie. Le MM était de type IgG lambda dans 32,63 % des cas avec une médiane de chaînes libres dans le sang à 2530 mg/L. Tous les patients ont été hémodialysés au moment du diagnostic. Au total, 24 % des patients avaient un traitement incluant du bortézomib, 67 % avaient un traitement incluant du melphalan et 9 % des patients n'avaient pas reçu de traitement. L'évolution était marquée par le sevrage de l'hémodialyse chez 45,83 % des patients dans un délai moyen de 20,19 jours. Au cours de suivi, 20 % des patients avaient une rémission partielle, 8 % avaient une rémission complète. Au total, 32 % de décès avec une médiane de survie globale de 26 mois. Les patients sevrés d'hémodialyse semblaient avoir une meilleure survie avec une médiane de 12 mois. Les causes de décès étaient essentiellement les causes septiques dans 42 % des cas. L'atteinte rénale conditionne la prise en charge et le pronostic de MM. L'évaluation de la réponse rénale est d'un intérêt capital, et les facteurs associés à la récupération rénale devraient être étudiés davantage. Le recours à l'hémodialyse constitue un facteur de risque péjoratif de morbi-mortalité au cours du myélome multiple. Des études impliquant l'utilisation précoce des membranes de très haute perméabilité ont permis un meilleur sevrage de dialyse. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Presenting the COGNIFOG Framework: Architecture, Building Blocks and Road toward Cognitive Connectivity.
- Author
-
Adame T, Amri E, Antonopoulos G, Azaiez S, Berne A, Camargo JS, Kakoulidis H, Kleisarchaki S, Llamedo A, Prasinos M, Psara K, and Shumaiev K
- Abstract
In the era of ubiquitous computing, the challenges imposed by the increasing demand for real-time data processing, security, and energy efficiency call for innovative solutions. The emergence of fog computing has provided a promising paradigm to address these challenges by bringing computational resources closer to data sources. Despite its advantages, the fog computing characteristics pose challenges in heterogeneous environments in terms of resource allocation and management, provisioning, security, and connectivity, among others. This paper introduces COGNIFOG, a novel cognitive fog framework currently under development, which was designed to leverage intelligent, decentralized decision-making processes, machine learning algorithms, and distributed computing principles to enable the autonomous operation, adaptability, and scalability across the IoT-edge-cloud continuum. By integrating cognitive capabilities, COGNIFOG is expected to increase the efficiency and reliability of next-generation computing environments, potentially providing a seamless bridge between the physical and digital worlds. Preliminary experimental results with a limited set of connectivity-related COGNIFOG building blocks show promising improvements in network resource utilization in a real-world-based IoT scenario. Overall, this work paves the way for further developments on the framework, which are aimed at making it more intelligent, resilient, and aligned with the ever-evolving demands of next-generation computing environments.
- Published
- 2024
- Full Text
- View/download PDF
12. Carriage Rate of Enterobacterales Resistant to Extended-Spectrum Cephalosporins in the Tunisian Population.
- Author
-
Mahjoub Khachroub A, Souguir M, Châtre P, Elhouda Bouhlel N, Jaidane N, Drapeau A, El Kantaoui M, Azaiez S, Madec JY, Mansour W, and Haenni M
- Abstract
Enterobacterales resistant to extended-spectrum cephalosporins (ESC) are a marker of the antimicrobial resistance (AMR) burden. They are infecting humans, but the intestinal microbiota can also be transiently colonized without developing symptoms. Healthy carriage can promote silent dissemination of resistant bacteria, and data on this colonization are often lacking. Between 2021 and 2023, a sampling of healthy Tunisian people was carried out. Fecal samples (n = 256) were plated on selective agar, and all collected isolates were characterized by phenotypic (antibiograms) and genomic (whole-genome sequencing) methods. A total of 26 (26/256, 10.2%) isolates were collected, including 24 Escherichia coli and 2 Klebsiella pneumoniae . In total, 17 isolates (15 E. coli and 2 K. pneumoniae ) presented an ESBL phenotype conferred by the bla
CTX-M-15 gene, and 9 E. coli isolates presented an AmpC phenotype conferred by the blaDHA-1 gene. K. pneumoniae belonged to ST1564 and ST313, while E. coli belonged to diverse STs including the pandemic ST131 clone. Clonally related ST349 E. coli isolates carrying the blaDHA-1 gene were found in nine individuals. In parallel, four blaCTX-M-15 -positive E. coli isolates carried this ESC-resistance gene on an epidemic plasmid IncF/F-:A-:B53 previously identified in Tunisian pigeons and fish. These findings highlight the spread of genetically diverse ESC-resistant Enterobacterales as well as an epidemic plasmid in Tunisia, emphasizing the need for antimicrobial stewardship to limit the transmission of these resistances in the Tunisian population.- Published
- 2024
- Full Text
- View/download PDF
13. Occurrence and persistence of multidrug-resistant Enterobacterales isolated from urban, industrial and surface water in Monastir, Tunisia.
- Author
-
Ncir S, Haenni M, Châtre P, Drapeau A, François P, Chaouch C, Souguir M, Azaiez S, Madec JY, and Mansour W
- Subjects
- Humans, beta-Lactamases genetics, Tunisia, Cephalosporins, Microbial Sensitivity Tests, Escherichia coli, Anti-Bacterial Agents pharmacology
- Abstract
The One Health approach of antimicrobial resistance highlighted the role of the aquatic environment as a reservoir and dissemination source of resistance genes and resistant bacteria, especially due to anthropogenic activities. Resistance to extended-spectrum cephalosporins (ESC) conferred by extended-spectrum beta-lactamases (ESBLs) in E. coli has been proposed as the major marker of the AMR burden in cross-sectoral approaches. In this study, we investigated wastewater, surface water and seawater that are subjected to official water quality monitoring in Monastir, Tunisia. While all but one sample were declared compliant according to the official tests, ESC-resistant bacteria were detected in 31 (19.1 %) samples. Thirty-nine isolates, coming from urban, industrial and surface water in Monastir, were collected and characterized using antibiograms and whole-genome sequencing. These isolates were identified as 27 Escherichia coli (69.3 %) belonging to 13 STs, 10 Klebsiella pneumoniae (25.6 %) belonging to six STs, and two Citrobacter freundii (5.1 %). We observed the persistence and dissemination of clones over time and in different sampling sites, and no typically human-associated pathogens could be identified apart from one ST131. All isolates presented a bla
CTX-M gene - blaCTX-M-15 (n = 22) and blaCTX-M-55 (n = 8) being the most frequent variants - which were identified on plasmids (n = 20) or on the chromosome (n = 19). In conclusion, we observed ESC resistance in rather ubiquitous bacteria that are capable of surviving in the water environment. This suggests that including the total coliform count and the ESBL count as determined by bacterial growth on selective plates in the official monitoring would greatly improve water quality control in Tunisia., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
14. CTX-M-15/27-positive Escherichia coli and VIM-2-producing Pseudomonas putida in free-living pigeons (Columba livia) in Tunisia.
- Author
-
Souguir M, Châtre P, Drapeau A, Azaiez S, Hmidi I, Ncir S, Lupo A, Madec JY, Haenni M, and Mansour W
- Subjects
- Animals, Humans, Columbidae genetics, Escherichia coli, Multilocus Sequence Typing, Tunisia epidemiology, Phylogeny, beta-Lactamases genetics, Pseudomonas putida genetics, Anti-Infective Agents
- Abstract
Objectives: Wild birds are vectors of antimicrobial resistance. Birds living in close contact with humans or other animals, like feral pigeons (Columba livia), might be especially prone to acquire resistance genes such as those encoding extended-spectrum beta-lactamases (ESBLs) and carbapenemases., Methods: Cloacal samples (n = 206) of free-living feral pigeons (C. livia) were collected in Sousse and Monastir, Tunisia. Antimicrobial susceptibility profiles were determined by disc-diffusion, and resistant isolates were short- and long-read whole-genome sequenced. Sequence analysis was performed using tools of the Centre for Genomic Epidemiology, and Phylogenetic analysis was performed based on the core-genome MLST., Results: Fourteen (14/206, 6.8%) pigeons harboured Enterobacterales resistant to last-generations cephalosporins, of which 10 were CTX-M-15- or CTX-M-27-producers, while two (1.0%) carried a VIM-2-producing Pseudomonas putida. Positive pigeons lived on four different livestock farms. Three STs (ST206, ST5584, ST8149) were identified among E. coli, of which ST5584 and ST8149 were found in two different farms. Genetic diversity was also observed in Enterobacter cloacae and P. putida isolates. The bla
CTX-M-27 genes were chromosomally encoded, while the blaCTX-M-15 genes were carried on highly similar IncF/F-:A-:B53 plasmids. The blaVIM-2 gene was located on a class 1 integron co-harbouring several resistance genes., Conclusion: Pigeons living on livestock farms carried clinically important resistance genes encoding ESBLs and carbapenemases. Our results evidenced that both clonal (ST8149 and ST5584) and plasmidic (IncF/F-:A-:B53) transfers played a role in the spread of resistance genes among pigeons. Further studies are needed to identify factors favouring the transfer and persistence of resistance genes within the pigeon communities., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
15. Prevalence of chronic kidney disease in Tunisian diabetics: the TUN-CKDD survey.
- Author
-
Labidi J, Harzallah A, Kaab BB, Mami I, Agrebi S, Azzabi A, Chargui S, Hadj-Brahim M, Hammouda M, Azaiez S, Tlili S, Lajili O, Antit H, Hasni Y, Chenik S, Chelbi F, Rais L, and Skhiri H
- Subjects
- Aged, Female, Humans, Male, Albuminuria diagnosis, Cross-Sectional Studies, Glomerular Filtration Rate, Prevalence, Risk Factors, Middle Aged, Diabetes Mellitus, Diabetic Nephropathies diagnosis, Renal Insufficiency, Chronic diagnosis
- Abstract
Background: In Tunisia, the prevalence of diabetes mellitus increased from 15.5% on 2016 to 23% by 2023. While Chronic Kidney Disease (CKD) stills the most dreaded complications of diabetes, studies on the prevalence of chronic kidney disease non-dialysis diet are scarce. The aim of this study was to assess the prevalence of chronic kidney disease among the Tunisian diabetic population based on investigators' specialty, demographic criteria (gender, age, duration of diabetes and geographic distribution) and diagnosis criteria (albuminuria and/or eGFR)., Methods: This observational, multicentric, and cross-sectional study enrolled all diabetic subjects from all regions of Tunisia with at least 3 months of follow-up before the inclusion date, from 09 January to 08 February 2023. CKD diagnosis was established based on the KDIGO guidelines. The study was carried out at medical departments and ambulatory clinics of different healthcare providers. Baseline data were collected by investigators using an electronic case report form (eCRF). Continuous variables were described by means, median, standard deviation, and quartiles. Categorical data were tabulated in frequencies and percentages., Results: The overall prevalence of CKD among the 10,145 enrolled patients with diabetes mellitus was 38.7% with a 95%CI [37.8-39.6%]. 50.9% were male, with a mean age of 67.5 (± 11.3) years. The mean diabetes duration was 16.1 years (± 8.9). The highest CKD prevalence was noted among nephrologists (82.2%), while it was similar between the cardiologists and the primary care physicians (30.0%). CKD prevalence was highest among males (43.0% versus 35.1%) and increased proportionally with patients' age and diabetes duration. CKD was more frequent in the Mid-East Area when compared to other regions (49.9% versus 25.3 to 40.1% in other regions). Albuminuria was present within 6.6% of subjects with CKD, and it was found an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m² within 13.3% of subjects wit h CKD. 18.9% had both criteria., Conclusions: In Tunisia, CKD among diabetics had a prevalence of 38.7%, approaching European prevalence. The prevalence discrepancy worldwide of CKD can be improved with a larger population size and by implementing standardized practices., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
16. Healthcare Equipment and Personnel Reservoirs of Carbapenem-Resistant Acinetobacter baumannii Epidemic Clones in Intensive Care Units in a Tunisian Hospital.
- Author
-
Azaiez S, Haenni M, Cheikh AB, Chalbi MS, Messaoudi A, Tilouch L, Bahri S, Drapeau A, Saras E, Mtibâa M, Zouaoui R, Said H, Madec JY, Lupo A, and Mansour W
- Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) strains can cause severe and difficult-to-treat infections in patients with compromised general health. CRAB strains disseminate rapidly in nosocomial settings by patient-to-patient contact, through medical devices and inanimate reservoirs. The occurrence of CRAB in patients residing in the intensive care units (ICUs) of the Sahloul University hospital in Sousse, Tunisia is high. The objective of the current study was to determine whether the surfaces of items present in five ICU wards and the medical personnel there operating could serve as reservoirs for CRAB strains. Furthermore, CRAB isolates from patients residing in the ICUs during the sampling campaign were analyzed for genome comparison with isolates from the ICUs environment. Overall, 206 items were screened for CRAB presence and 27 (14%) were contaminated with a CRAB isolate. The items were located in several areas of three ICUs. Eight of the 54 (15%) screened people working in the wards were colonized by CRAB on the hands. Patients residing in the ICUs were infected with CRAB strains sharing extensive genomic similarity with strains recovered in the nosocomial environment. The strains belonged to three sub-clades of the internationally disseminated clone (ST2). A clone emerging in the Mediterranean basin (ST85) was detected as well. The strains were OXA-23 or NDM-1 producers and were also pan-aminoglycoside resistant due to the presence of the armA gene. Hygiene measures are urgent to be implemented in the Sahloul hospital to avoid further spread of difficult-to-treat CRAB strains and preserve health of patients and personnel operating in the ICU wards.
- Published
- 2023
- Full Text
- View/download PDF
17. Molecular characterization of highly prevalent Escherichia coli and Escherichia marmotae resistant to extended-spectrum cephalosporins in European starlings ( Sturnus vulgaris ) in Tunisia.
- Author
-
Souguir M, Châtre P, Drapeau A, François P, Azaiez S, Ncir S, Madec JY, Mansour W, and Haenni M
- Abstract
European starlings are widespread migratory birds that have already been described as carrying bacteria resistant to extended-spectrum cephalosporins (ESC-R). These birds are well known in Tunisia because they spend the wintertime in this country and are hunted for human consumption. The goal of our study was to estimate the proportion of ESC-R in these birds and to characterize the collected isolates using whole-genome sequencing. Results showed that 21.5% (42/200) of the birds carried either an extended-spectrum beta-lactamase (ESBL) or an acquired AmpC gene. Diverse bla
CTX-M genes were responsible for the ESBL phenotype, blaCTX-M-14 being the most prevalent, while only blaCMY-2 and one blaCMY-62 were found in AmpC-positive isolates. Likewise, different genetic determinants carried these resistance genes, including IncHI2, and IncF plasmids for blaCTX-M genes and IncI1 plasmids for blaCMY-2 genes. Three chromosomally encoded blaCTX-M-15 genes were also identified. Surprisingly, species identification revealed a large proportion (32.7%) of Escherichia marmotae isolates. This species is phenotypically indistinguishable from Escherichia coli and has obviously the same capacity to acquire ESC-R genes. Our data also strongly suggest that at least the IncHI2/pST3 plasmid can spread equally between E. coli and E. marmotae . Given the potential transmission routes between humans and animals, either by direct contact with dejections or through meat preparation, it is important to closely monitor antimicrobial resistance in European starlings in Tunisia and to set up further studies to identify the sources of contamination of these birds. IMPORTANCE The One Health concept highlighted knowledge gaps in the understanding of the transmission routes of resistant bacteria. A major interest was shown in wild migratory birds since they might spread resistant bacteria over long distances. Our study brings further evidence that wild birds, even though they are not directly submitted to antibiotic treatments, can be heavily contaminated by resistant bacteria. Our results identified numerous combinations of resistance genes, genetic supports, and bacterial clones that can spread vertically or horizontally and maintain a high level of resistance in the bird population. Some of these determinants are widespread in humans or animals (IncHI2/pST3 plasmids and pandemic clones), while some others are less frequent (atypical IncI1 plasmid and minor clones). Consequently, it is essential to be aware of the risks of transmission and to take all necessary measures to prevent the proportions of resistant isolates from increasing uncontrollably.- Published
- 2023
- Full Text
- View/download PDF
18. Clonal, Plasmidic and Genetic Diversity of Multi-Drug-Resistant Enterobacterales from Hospitalized Patients in Tripoli, Libya.
- Author
-
Elgriw N, Métayer V, Drapeau A, François P, Azaiez S, Mastouri M, Rhim H, Elzagheid A, Soufiyah N, Madec JY, Chaouch C, Mansour W, and Haenni M
- Abstract
Resistance to extended-spectrum cephalosporins (ESC) and carbapenems in Enterobacterales is a major issue in public health. Carbapenem resistance in particular is associated with increased morbidity and mortality. Moreover, such resistance is often co-harbored with resistance to non-beta-lactam antibiotics, and pathogens quickly become multi-drug-resistant (MDR). Only a few studies have been published on AMR in Libyan hospitals, but all reported worrisome results. Here, we studied 54 MDR isolates that were collected from 49 patients at the Tripoli University Hospital between 2019 and 2021. They were characterized using phenotypic methods, PCR and PFGE, and a sub-set of isolates were short- and long-read whole-genome sequenced. The results showed the frequent occurrence of Klebsiella pneumoniae (49/54), among which several high-risk clones were responsible for the spread of resistance, namely, ST11, ST17, ST101 and ST147. ESC and carbapenem resistance was due to a wide variety of enzymes (CTX-M, OXA-48, NDM, KPC), with their corresponding genes carried by different plasmids, including IncF-IncHI2 and IncF-IncR hybrids. This study highlights that implementation of infection prevention, control and surveillance measures are needed in Libya to fight against AMR.
- Published
- 2023
- Full Text
- View/download PDF
19. First characterization of the intestinal microbiota in healthy Tunisian adults using 16S rRNA gene sequencing.
- Author
-
Mahjoub Khachroub A, Monnoye M, Bouhlel NE, Azaiez S, Ben Fredj M, Mansour W, and Gérard P
- Subjects
- Male, Female, Humans, Adult, RNA, Ribosomal, 16S genetics, Genes, rRNA, Overweight genetics, Feces microbiology, Firmicutes genetics, Gastrointestinal Microbiome genetics
- Abstract
The gut microbiota is currently recognized as an important factor influencing the host's metabolism, immune, and central nervous systems. Determination of the composition of the gut microbiota of healthy subjects is therefore necessary to establish a baseline for the detection of alterations in the microbiota under pathological conditions. So far, most studies describing the gut microbiota have been performed in populations from Asia, North America, and Europe, whereas populations from Africa have been overlooked. Here, we present the first characterization of the intestinal microbiota in healthy Tunisian adults using 16S rRNA gene sequencing. We further compare the gut microbiota composition based on gender and BMI. Our results showed that the Tunisian gut microbiota is dominated by the phyla Firmicutes and Bacteroidota in accordance with studies from western countries. However, some specificities have been identified, including a higher proportion of Firmicutes in males and higher proportions of Atopobiaceae and Peptostreptococcaceae in Tunisian overweight individuals. Moreover, we were able to identify bacterial species differently represented between males and females and between normal weight and overweight individuals. These results constitute an important baseline that can be used to identify the dysbiosis associated with the main diseases affecting the Tunisian population., (© The Author(s) 2023. Published by Oxford University Press on behalf of FEMS.)
- Published
- 2023
- Full Text
- View/download PDF
20. Back to the Origin: bla OXA-204 and bla NDM-1 Genes in Shewanella spp. from a Tunisian River.
- Author
-
Ncir S, Lupo A, Drapeau A, Châtre P, Souguir M, Azaiez S, Madec JY, Mansour W, and Haenni M
- Subjects
- Rivers, beta-Lactamases genetics, Carbapenems, Microbial Sensitivity Tests, Anti-Bacterial Agents, Bacterial Proteins genetics, Shewanella genetics
- Published
- 2022
- Full Text
- View/download PDF
21. Design and Rationale of the National Tunisian Registry of Heart Failure (NATURE-HF): Protocol for a Multicenter Registry Study.
- Author
-
Abid L, Kammoun I, Ben Halima M, Charfeddine S, Ben Slima H, Drissa M, Mzoughi K, Mbarek D, Riahi L, Antit S, Ben Halima A, Ouechtati W, Allouche E, Mechri M, Yousfi C, Khorchani A, Abid O, Sammoud K, Ezzaouia K, Gtif I, Ouali S, Triki F, Hamdi S, Boudiche S, Chebbi M, Hentati M, Farah A, Triki H, Ghardallou H, Raddaoui H, Zayed S, Azaiez F, Omri F, Zouari A, Ben Ali Z, Najjar A, Thabet H, Chaker M, Mohamed S, Chouaieb M, Ben Jemaa A, Tangour H, Kammoun Y, Bouhlel M, Azaiez S, Letaief R, Maskhi S, Amri A, Naanaa H, Othmani R, Chahbani I, Zargouni H, Abid S, Ayari M, Ben Ameur I, Gasmi A, Ben Halima N, Haouala H, Boughzela E, Zakhama L, Ben Youssef S, Nasraoui W, Boujnah MR, Barakett N, Kraiem S, Drissa H, Ben Khalfallah A, Gamra H, Kachboura S, Bezdah L, Baccar H, Milouchi S, Sdiri W, Ben Omrane S, Abdesselem S, Kanoun A, Hezbri K, Zannad F, Mebazaa A, Kammoun S, Mourali MS, and Addad F
- Abstract
Background: The frequency of heart failure (HF) in Tunisia is on the rise and has now become a public health concern. This is mainly due to an aging Tunisian population (Tunisia has one of the oldest populations in Africa as well as the highest life expectancy in the continent) and an increase in coronary artery disease and hypertension. However, no extensive data are available on demographic characteristics, prognosis, and quality of care of patients with HF in Tunisia (nor in North Africa)., Objective: The aim of this study was to analyze, follow, and evaluate patients with HF in a large nation-wide multicenter trial., Methods: A total of 1700 patients with HF diagnosed by the investigator will be included in the National Tunisian Registry of Heart Failure study (NATURE-HF). Patients must visit the cardiology clinic 1, 3, and 12 months after study inclusion. This follow-up is provided by the investigator. All data are collected via the DACIMA Clinical Suite web interface., Results: At the end of the study, we will note the occurrence of cardiovascular death (sudden death, coronary artery disease, refractory HF, stroke), death from any cause (cardiovascular and noncardiovascular), and the occurrence of a rehospitalization episode for an HF relapse during the follow-up period. Based on these data, we will evaluate the demographic characteristics of the study patients, the characteristics of pathological antecedents, and symptomatic and clinical features of HF. In addition, we will report the paraclinical examination findings such as the laboratory standard parameters and brain natriuretic peptides, electrocardiogram or 24-hour Holter monitoring, echocardiography, and coronarography. We will also provide a description of the therapeutic environment and therapeutic changes that occur during the 1-year follow-up of patients, adverse events following medical treatment and intervention during the 3- and 12-month follow-up, the evaluation of left ventricular ejection fraction during the 3- and 12-month follow-up, the overall rate of rehospitalization over the 1-year follow-up for an HF relapse, and the rate of rehospitalization during the first 3 months after inclusion into the study., Conclusions: The NATURE-HF study will fill a significant gap in the dynamic landscape of HF care and research. It will provide unique and necessary data on the management and outcomes of patients with HF. This study will yield the largest contemporary longitudinal cohort of patients with HF in Tunisia., Trial Registration: ClinicalTrials.gov NCT03262675; https://clinicaltrials.gov/ct2/show/NCT03262675., International Registered Report Identifier (irrid): DERR1-10.2196/12262., (©Leila Abid, Ikram Kammoun, Manel Ben Halima, Salma Charfeddine, Hedi Ben Slima, Meriem Drissa, Khadija Mzoughi, Dorra Mbarek, Leila Riahi, Saoussen Antit, Afef Ben Halima, Wejdene Ouechtati, Emna Allouche, Mehdi Mechri, Chedi Yousfi, Ali Khorchani, Omar Abid, Kais Sammoud, Khaled Ezzaouia, Imen Gtif, Sana Ouali, Feten Triki, Sonia Hamdi, Selim Boudiche, Marwa Chebbi, Mouna Hentati, Amani Farah, Habib Triki, Houda Ghardallou, Haythem Raddaoui, Sofien Zayed, Fares Azaiez, Fadwa Omri, Akram Zouari, Zine Ben Ali, Aymen Najjar, Houssem Thabet, Mouna Chaker, Samar Mohamed, Marwa Chouaieb, Abdelhamid Ben Jemaa, Haythem Tangour, Yassmine Kammoun, Mahmoud Bouhlel, Seifeddine Azaiez, Rim Letaief, Salah Maskhi, Aymen Amri, Hela Naanaa, Raoudha Othmani, Iheb Chahbani, Houcine Zargouni, Syrine Abid, Mokdad Ayari, Ines ben Ameur, Ali Gasmi, Nejeh ben Halima, Habib Haouala, Essia Boughzela, Lilia Zakhama, Soraya ben Youssef, Wided Nasraoui, Mohamed Rachid Boujnah, Nadia Barakett, Sondes Kraiem, Habiba Drissa, Ali Ben Khalfallah, Habib Gamra, Salem Kachboura, Leila Bezdah, Hedi Baccar, Sami Milouchi, Wissem Sdiri, Skander Ben Omrane, Salem Abdesselem, Alifa Kanoun, Karima Hezbri, Faiez Zannad, Alexandre Mebazaa, Samir Kammoun, Mohamed Sami Mourali, Faouzi Addad. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 27.10.2021.)
- Published
- 2021
- Full Text
- View/download PDF
22. First report of carbapenemase OXA-181-producing Serratia marcescens.
- Author
-
Messaoudi A, Mansour W, Tilouche L, Châtre P, Drapeau A, Chaouch C, Azaiez S, Bouallègue O, Madec JY, and Haenni M
- Subjects
- Bacterial Proteins genetics, Serratia marcescens genetics, beta-Lactamases genetics
- Published
- 2021
- Full Text
- View/download PDF
23. Prevalence and risk factors of hypogonadism in men with chronic renal failure.
- Author
-
Oueslati I, Ounissi M, Talbi E, Azaiez S, Bacha MM, and Ben Abdallah T
- Subjects
- Adult, Cross-Sectional Studies, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 epidemiology, Diabetic Nephropathies blood, Diabetic Nephropathies complications, Diabetic Nephropathies diagnosis, Diabetic Nephropathies epidemiology, Gonadotropins blood, Humans, Hypogonadism blood, Hypogonadism diagnosis, Kidney Failure, Chronic blood, Male, Middle Aged, Prevalence, Prolactin blood, Risk Factors, Testosterone blood, Hypogonadism epidemiology, Hypogonadism etiology, Kidney Failure, Chronic complications, Kidney Failure, Chronic epidemiology
- Abstract
Aim: To determine the prevalence and the risk factors of hypogonadism in men with chronic renal failure (CRF)., Methods: We conducted a cross sectional analysis in 48 men with CRF. Total testosterone, prolactin, and gonadotropins were measured in all patients. Hypogonadism was defined by a low level (<10 nmol/l) or a low normal level (10-14 nmol/l) of total testosterone., Results: The mean age was 53.31±10.22 years. Renal impairment was mild, moderate, severe and at end stage in 9,14,4 and 21 patients, respectively. Nineteen patients had been undergoing extra-renal purification. The average of total testosterone was 13.44±6.17 nmol/L. It was lower in patients with diabetic nephropathy (p=0.004). Hypogonadism was diagnosed in 22 patients (46 %). In this group, gonadotropins were normal in 21 cases and elevated in only one case. Hyperprolactinemia was retained in six patients. Type 2 diabetes (OR: 3.96; p=0.02) and diabetic nephropathy (OR=4.26; p=0.01) were the only risk factors of hypogonadism in our patients., Conclusion: Our results had demonstrated a high prevalence of hypogonadism in males with chronic renal failure. This hormone disorder was associated with type 2 diabetes and diabetic nephropathy.
- Published
- 2020
24. Biological control of the soft rot bacterium Pectobacterium carotovorum by Bacillus amyloliquefaciens strain Ar10 producing glycolipid-like compounds.
- Author
-
Azaiez S, Ben Slimene I, Karkouch I, Essid R, Jallouli S, Djebali N, Elkahoui S, Limam F, and Tabbene O
- Subjects
- Anti-Bacterial Agents chemistry, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents metabolism, Bacillus amyloliquefaciens classification, Bacillus amyloliquefaciens genetics, Bacillus amyloliquefaciens isolation & purification, Biological Control Agents chemistry, Biological Control Agents isolation & purification, Biological Control Agents metabolism, Endophytes, Glycolipids chemistry, Glycolipids isolation & purification, Glycolipids metabolism, Kinetics, Microbial Sensitivity Tests, Pectobacterium carotovorum isolation & purification, Pectobacterium carotovorum pathogenicity, Plant Diseases microbiology, Plant Roots drug effects, Plant Roots microbiology, Solanum tuberosum microbiology, Anti-Bacterial Agents pharmacology, Bacillus amyloliquefaciens metabolism, Biological Control Agents antagonists & inhibitors, Glycolipids antagonists & inhibitors, Pectobacterium carotovorum drug effects, Plant Diseases prevention & control
- Abstract
Four hundred and fifty bacteria were evaluated for antagonistic activity against bacterial soft rot of potato caused by Pectobacterium carotovorum sp strain II16. A strain Ar10 exhibiting potent antagonist activity has been identified as Bacillus amyloliquefaciens on the basis of biochemical and molecular characterization. Cell free supernatant showed a broad spectrum of antibacterial activity against human and phytopathogenic bacteria in the range of 10-60 AU/mL. Incubation of P. carotovorum cells with increasing concentrations of the antibacterial compound showed a killing rate of 94.8 and 96% at MIC and 2xMIC respectively. In addition, the antibacterial agent did not exert haemolytic activity at the active concentration and has been preliminary characterized by TLC and GC-MS as a glycolipid compound. Treatment of potato tubers with strain Ar10 for 72 h significantly reduced the severity of disease symptoms (100 and 85.05% reduction of necrosis deep / area and weight loss respectively). The same levels in disease symptoms severity was also recorded following treatment of potato tubers with cell free supernatant for 1 h. Data suggest that protection against potato soft rot disease may be related to glycolipid production by strain Ar10. The present study affords new alternatives for anti-Pectobacterium carotovorum bioactive compounds against the soft rot disease of potato., (Copyright © 2018 Elsevier GmbH. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
25. Enhancement of Exochitinase Production by Bacillus licheniformis AT6 Strain and Improvement of N-Acetylglucosamine Production.
- Author
-
Aounallah MA, Slimene-Debez IB, Djebali K, Gharbi D, Hammami M, Azaiez S, Limam F, and Tabbene O
- Subjects
- Acetylglucosamine isolation & purification, Hexosaminidases chemistry, Hexosaminidases isolation & purification, Hexosaminidases metabolism, Species Specificity, Acetylglucosamine biosynthesis, Bacillus licheniformis classification, Bacillus licheniformis metabolism, Culture Media chemistry, Culture Media metabolism, Solanum tuberosum microbiology
- Abstract
A strain producing chitinase, isolated from potato stem tissue, was identified as Bacillus licheniformis by biochemical properties and 16S RNA sequence analysis. Statistical experimental designs were used to optimize nine independent variables for chitinase production by B. licheniformis AT6 strain in submerged fermentation. Using Plackett-Burman design, (NH
4 )2 SO4 , MgSO4 .7H2 O, colloidal chitin, MnCl2 2H2 O, and temperature were found to influence chitinase production significantly. According to Box-Behnken response surface methodology, the optimal fermentation conditions allowing maximum chitinase production were (in gram per liter): (NH4 )2 SO4 , 7; K2 HPO4 , 1; NaCl, 1; MgSO4 .7H2 O, 0.1; yeast extract, 0.5; colloidal chitin, 7.5; MnCl2 .2H2 O, 0.2; temperature 35 °C; pH medium 7. The optimization strategy led to a 10-fold increase in chitinase activity (505.26 ± 22.223 mU/mL versus 50.35 ± 19.62 mU/mL for control basal medium). A major protein band with a molecular weight of 61.9 kDa corresponding to chitinase activity was clearly detected under optimized conditions. Chitinase activity produced in optimized medium mainly releases N-acetyl glucosamine (GlcNAc) monomer from colloidal chitin. This enzyme also acts as an exochitinase with β-N-acetylglucosaminidase. These results suggest that B. licheniformis AT6 secreting exochitinase is highly efficient in GlcNAc production which could in turn be envisaged as a therapeutic agent or as a conservator against the alteration of several ailments.- Published
- 2017
- Full Text
- View/download PDF
26. Relationship between the A(8002)G intronic polymorphism of pre-pro-endothelin-1 gene and the endothelin-1 concentration among Tunisian coronary patients.
- Author
-
Chalghoum A, Noichri Y, Dandana A, Azaiez S, Baudin B, Jeridi G, Miled A, and Ferchichi S
- Subjects
- Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome epidemiology, Aged, Female, Gene Frequency, Genetic Association Studies, Genetic Markers, Genetic Predisposition to Disease, Heterozygote, Homozygote, Humans, Male, Middle Aged, Phenotype, Retrospective Studies, Risk Assessment, Risk Factors, Tunisia epidemiology, Up-Regulation, Acute Coronary Syndrome blood, Acute Coronary Syndrome genetics, Endothelin-1 blood, Endothelin-1 genetics, Introns, Polymorphism, Genetic
- Abstract
Background: Acute coronary syndromes (ACS) are complex and polygenic diseases which are a real problem of public health. These syndromes require multidisciplinary studies to understand the pathogenesis mechanisms. Our study aims to evaluate the endothelin-1 (ET-1) serum concentration in Tunisian coronary compared to controls healthy, as well as the study of the impact of an intronic polymorphism A (8002) G of pre-pro-endothelin-1 Gene (inactive precursor of ET-1) on the change in serum endothelin-1 and in the susceptibility to Acute coronary syndrome (SCA)., Methods: Our samples were subdivided into coronary patients (157) and healthy subjects (142). The quantification of the ET-1 concentration was performed by high performance liquid chromatography, the identification of the different genotypes of the polymorphism A(8002)G was made by PCR-RFLP. The association between the ET-1 concentration and identified genotypes was realized by adapted software for descriptive statistics, Statistical Package for the Sociological Sciences (SPSS v 21.0)., Results: Our study showed that the concentration of ET-1 was significantly higher in patients compared to controls and that the mutated allele prevails in patients F (G) = 0.78 and there is a minority in controls F (G) = 0.3. Secondly the homozygous genotype GG is associated with higher concentrations of ET-1 in patients and controls, heterozygous genotype AG is associated with intermediaries' values and AA genotype is related to lower values., Conclusion: Although the polymorphism studied is an intronic polymorphism, it is involved in the change in serum concentration of ET-1 and is a candidate gene in susceptibility to SCA. Cardiovascular diseases are "polygenic" pathology and do not obey of the law for transmission of Mendel.
- Published
- 2015
- Full Text
- View/download PDF
27. Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species.
- Author
-
Tabbene O, Di Grazia A, Azaiez S, Ben Slimene I, Elkahoui S, Alfeddy MN, Casciaro B, Luca V, Limam F, and Mangoni ML
- Subjects
- Antimicrobial Cationic Peptides, Microbial Sensitivity Tests, Microbial Viability drug effects, Amphotericin B pharmacology, Antifungal Agents pharmacology, Candida drug effects, Drug Synergism, Lipopeptides pharmacology, Peptides pharmacology, Polyenes pharmacology
- Abstract
In the present study, the synergism of the lipopeptide bacillomycin D in combination with the polyene amphotericin B against pathogenic Candida species is described along with their potential cytotoxicity against mammalian cells. Bacillomycin D inhibited the growth of various Candida species at minimal concentrations from 12.5 to 25 μg ml(-1). Furthermore, it showed a synergistic effect with the antifungal drug amphotericin B in inhibiting the growth of Candida strains, with fractional inhibitory concentration indices ranging from 0.28 to 0.5. Time killing studies revealed a >2-log reduction in the viability of Candida albicans ATCC 10231 cells after 3 h incubation with the combination amphotericin B plus bacillomycin D, at their subinhibitory concentration. Interestingly, when the two drugs were used together at those dosages displaying a synergism in the anti-Candida activity, no cytotoxic effect was observed against mammalian cells. Therefore, the combination bacillomycin D/amphotericin B may represent a valid alternative to conventional antifungals for topical treatment of C. albicans infections. To the best of our knowledge, this is the first report describing the in vitro interaction between the antifungal drug amphotericin B and bacillomycin D against pathogenic Candida species., (© FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
28. Antifungal activity of volatile compounds-producing Pseudomonas P2 strain against Rhizoctonia solani.
- Author
-
Elkahoui S, Djébali N, Yaich N, Azaiez S, Hammami M, Essid R, and Limam F
- Subjects
- Bacterial Typing Techniques, Base Composition, Cluster Analysis, DNA, Bacterial chemistry, DNA, Bacterial genetics, DNA, Ribosomal chemistry, DNA, Ribosomal genetics, Microscopy, Molecular Sequence Data, Phylogeny, Pseudomonas classification, Pseudomonas genetics, Pseudomonas isolation & purification, RNA, Ribosomal, 16S genetics, Rhizoctonia cytology, Sequence Analysis, DNA, Antifungal Agents metabolism, Pseudomonas metabolism, Rhizoctonia drug effects, Volatile Organic Compounds metabolism
- Abstract
Several volatile organic compounds (VOCs) producing endophyte bacteria were isolated from the leaves of olive trees and tested for their antifungal activity against several pathogenic fungi. An antagonistic strain called P2 showed 97 % of homology with Pseudomonas sp. strains on the basis of its 16S rDNA sequence and biochemical properties. P2 strain drastically inhibited the growth of Rhizoctonia solani mycelia (86 %) at 5 day-post-confrontation (dpc) and strongly reduced fungi infection on potato slices at 10(7) bacteria ml(-1) for 3 and 7 dpc. P2 strain was also positive for protease activity as well as siderophore production. Light microscopy analysis showed that treatment of R. solani mycelia with P2 strain induced thickening of the cell-wall, vesiculation of protoplasm and blockage of fungal hyphae branching. VOCs analysis using GC-MS allowed the detection of two major products with m/z of 93.9910 and 125.9630 corresponding to dimethyl disulfide and dimethyl trisulfide respectively. VOCs-producing P2 strain could be a promising agent in the protection of tuber crops against fungal diseases.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.